<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom"  xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:georss="http://www.georss.org/georss" xmlns:photo="http://www.pheed.com/pheed/">
 <title>Daily CSR</title>
 <subtitle><![CDATA[Daily CSR delivers latest news and in-depth coverage about corporate social responsibility, ethics and sustainability]]></subtitle>
 <link rel="alternate" type="text/html" href="https://www.dailycsr.com" />
 <link rel="self" type="text/xml" href="https://www.dailycsr.com/xml/atom.xml" />
 <id>https://www.dailycsr.com/</id>
 <updated>2026-06-08T14:51:14+02:00</updated>
 <generator uri="http://www.wmaker.net">Webzine Maker</generator>
  <icon>https://www.dailycsr.com/favicon.ico</icon>
  <entry>
   <title>Gifthealth Wins Platinum for Top Digital Health Platform at Pinnacle Awards 2026</title>
   <updated>2026-04-24T14:16:00+02:00</updated>
   <id>https://www.dailycsr.com/Gifthealth-Wins-Platinum-for-Top-Digital-Health-Platform-at-Pinnacle-Awards-2026_a5743.html</id>
   <category term="Companies" />
   <photo:imgsrc>https://www.dailycsr.com/photo/art/imagette/96229645-67131608.jpg</photo:imgsrc>
   <published>2026-04-24T14:13:00+02:00</published>
   <author><name>Debashish Mukherjee</name></author>
   <content type="html">
    <![CDATA[
     <div style="position:relative; text-align : center; padding-bottom: 1em;">
      <img src="https://www.dailycsr.com/photo/art/default/96229645-67131608.jpg?v=1777032970" alt="Gifthealth Wins Platinum for Top Digital Health Platform at Pinnacle Awards 2026" title="Gifthealth Wins Platinum for Top Digital Health Platform at Pinnacle Awards 2026" />
     </div>
     <div>
      <div style="text-align: justify;">Gifthealth, a patient access platform that streamlines the prescription journey from provider to patient, has received the Platinum award for Top Digital Health Platform at the 2026 Pinnacle Awards. <br />   <br />  As the leading direct-to-patient (DTP) partner for pharmaceutical companies, Gifthealth is known for advancing digital-first brand experiences. Its unified platform connects life sciences innovations directly with patients through automated prescription routing, transparent real-time pricing, and engagement across multiple channels. <br />   <br />  The recognition highlights Gifthealth’s role in reshaping the prescription experience into a smooth, patient-focused process—bridging manufacturers, healthcare providers, and patients in ways traditional systems have not achieved. <br />   <br />  “We don’t take our mission lightly when we say we’re transforming the system,” said CEO Chip Parkinson. “We are fully committed to delivering bold solutions for our clients, partners, and every patient who depends on us. The responsibility is significant, but it fuels our drive to turn challenges into meaningful outcomes and better healthcare experiences.” <br />   <br />  Today, more than 175,000 prescribers rely on Gifthealth to help patients access medications more quickly and maintain adherence. With over six million completed patient journeys, the company is the first to successfully scale DTP delivery. Its Digi+Hub model has set new performance benchmarks, including:</div>    <ul>  	<li style="text-align: justify;">Dispense rates 50% above industry norms</li>  	<li style="text-align: justify;">Refill success rates 1.5 times the national average</li>  	<li style="text-align: justify;">50% lower abandonment rates</li>  	<li style="text-align: justify;">92% patient persistence compared to a 60% national benchmark</li>  	<li style="text-align: justify;">Customer satisfaction scores of 90%, versus 77% industry-wide</li>  	<li style="text-align: justify;">95% of prescriptions delivered within one day, compared to six days nationally</li>  </ul>    <div style="text-align: justify;">“Healthcare is evolving faster than ever, and this year’s winners exemplify excellence in innovation, empathy, and measurable impact,” said Kate Lang, Executive Director of the Pinnacle Awards. “From AI-powered diagnostics to patient-centric care delivery, these organizations are redefining the future of global healthcare.” <br />   <br />  Click <a class="link" href="https://www.gifthealth.com/">here</a>  to learn more about how Gifthealth provides a scalable and proven model that brings direct-to-patient solutions to life.</div>  
     </div>
     <br style="clear:both;"/>
    ]]>
   </content>
   <link rel="alternate" href="https://www.dailycsr.com/Gifthealth-Wins-Platinum-for-Top-Digital-Health-Platform-at-Pinnacle-Awards-2026_a5743.html" />
  </entry>
  <entry>
   <title>Teva’s Global Innovation Strategy: Advancing Healthcare Through Collaboration and Research</title>
   <updated>2025-06-18T08:03:00+02:00</updated>
   <id>https://www.dailycsr.com/Teva-s-Global-Innovation-Strategy-Advancing-Healthcare-Through-Collaboration-and-Research_a4873.html</id>
   <category term="Companies" />
   <photo:imgsrc>https://www.dailycsr.com/photo/art/imagette/89389906-63204221.jpg</photo:imgsrc>
   <published>2025-06-18T08:02:00+02:00</published>
   <author><name>Debashish Mukherjee</name></author>
   <content type="html">
    <![CDATA[
     <div style="position:relative; text-align : center; padding-bottom: 1em;">
      <img src="https://www.dailycsr.com/photo/art/default/89389906-63204221.jpg?v=1750226625" alt="Teva’s Global Innovation Strategy: Advancing Healthcare Through Collaboration and Research" title="Teva’s Global Innovation Strategy: Advancing Healthcare Through Collaboration and Research" />
     </div>
     <div>
      <div style="text-align: justify;"><strong>Advancing Access to Healthcare through Innovation and Partnerships</strong> <br />  Expanding access to medicines and healthcare relies on the continuous creation of evidence-driven solutions to address unmet medical needs. To support this mission, we actively engage in collaborative scientific efforts with academic institutions, research organizations, start-ups, pharmaceutical companies, hospitals, and health maintenance groups. <br />   <br />  These partnerships help us discover external innovations that complement our internal R&amp;D objectives. This collaborative approach enhances our scientific presence and accelerates the expansion of our innovative drug pipeline, aligning with the Step-up Innovation focus of our Pivot to Growth strategy. Ultimately, these initiatives aim to reduce the time needed for drug discovery and development and improve the likelihood of identifying successful therapeutic candidates. <br />   <br />  <strong>Our Model for Innovation and Collaboration</strong> <br />  Our innovation strategy is multi-faceted—bridging internal priorities (uncovered through team workshops and consultations) with external opportunities identified via detailed mapping, database analysis, AI-based scouting, and traditional methods. By being actively involved in key trade and industry associations, we strengthen our position within the global biotech ecosystem. As a trusted collaborator, we offer access to industry insights and the expertise of our skilled teams. <br />   <br />  <strong>Partnerships Across the U.S. and Europe</strong> <br />  In the United States, we have strategic innovation partnerships with top academic institutions including Harvard University, Thomas Jefferson University, University of Pittsburgh, University of Oklahoma, and University of Pennsylvania. <br />   <br />  In Europe, we’ve been an active participant in the Innovative Medicines Initiative (IMI)—Europe’s largest public-private partnership in life sciences—since 2019. This initiative supports the development of advanced vaccines, medicines, and treatment methods. As of 2024, we are involved in over eight IMI consortia, covering the full spectrum of drug development. Two of the latest projects focus on biologics and biomarker research:</div>    <ul>  	<li style="text-align: justify;"><strong>RealHOPE</strong>: Designed to improve guidelines for handling biologic medications by patients, caregivers, and pharmacies.</li>  	<li style="text-align: justify;"><strong>European Platform for Neurodegenerative Diseases (EPND)</strong>: Aims to create a comprehensive infrastructure for collecting and analyzing clinical and biological data to support biomarker discovery in neurodegenerative diseases.</li>  </ul>    <div style="text-align: justify;"><strong>Israel as a Strategic Innovation Hub</strong> <br />  Given our strong historical roots in Israel, the country plays a vital role in our global innovation efforts. Since re-establishing our focus there in 2020, we have initiated around 50 research collaborations with Israeli scientists. These projects have secured 18 grants from the Israel Innovation Authority, with two receiving additional funding in 2024. <br />   <br />  Key Israel-based innovation initiatives include:</div>    <ul>  	<li style="text-align: justify;"><strong>AION Labs</strong>: A collaborative venture between Teva, three other pharmaceutical giants, Amazon, and the Israel Biotech Fund, AION Labs fosters AI-driven start-ups in drug development. We support AION with mentorship and active involvement. In 2024, AION launched <em>CombinAble</em>, a start-up for antibody optimization, and we backed <em>Celleryx</em>, which applies AI for early detection of cancer and autoimmune conditions.</li>  	<li style="text-align: justify;"><strong>Organospheres</strong>: This multi-partner consortium, including start-ups, pharma firms, and academic researchers, is developing a human-based 3D ex-vivo system to potentially replace animal use in preclinical research.</li>  	<li style="text-align: justify;"><strong>BioInnovators Forum</strong>: We mentor and train 30 PhD and postdoctoral students annually in translational medicine through workshops and an innovation challenge aimed at addressing unmet clinical needs. Over 150 students have taken part since 2020. Notable 2024 projects included a breath-based tuberculosis detection kit and an IVF device enhancing embryo fertilization and implantation. This program also helps us identify top-tier scientific talent for our R&amp;D efforts.</li>  </ul>    <div style="text-align: justify;"><strong>Since 2020:</strong></div>    <ul>  	<li style="text-align: justify;">50 collaborations with Israeli scientists</li>  	<li style="text-align: justify;">18 grants awarded from the Israel Innovation Authority</li>  	<li style="text-align: justify;">150 BioInnovators Forum participants</li>  </ul>    <div style="text-align: justify;"><strong>Research into Public Health Needs</strong> <br />  Our research team gathers and interprets public health and epidemiological data to assess the clinical, economic, and social needs of patients in key therapeutic areas such as neurology, psychiatry, immunology, and oncology. We focus on understanding disease burden, testing innovative clinical education tools, and improving access to treatment. This data also supports trial design by helping to identify the most appropriate patient populations and inclusion criteria. In 2024, we presented findings at 176 scientific conferences and published 55 articles in peer-reviewed medical and scientific journals. <br />   <br />  <strong>Teva’s 2024 Academic Publications on PubMed (55 total):</strong></div>    <ul>  	<li style="text-align: justify;">33%: Research Innovation</li>  	<li style="text-align: justify;">29%: Neurology/Psychiatry</li>  	<li style="text-align: justify;">11%: Migraine</li>  	<li style="text-align: justify;">7%: Respiratory</li>  	<li style="text-align: justify;">7%: Oncology</li>  	<li style="text-align: justify;">5%: Immunology</li>  	<li style="text-align: justify;">4%: Cardiovascular</li>  	<li style="text-align: justify;">4%: Central Nervous System/Pain</li>  </ul>    <div style="text-align: justify;">Click <a class="link" href="https://www.tevapharm.com/globalassets/tevapharm-vision-files/teva-esg-progress-report-2024.pdf">here</a>  to read the complete 2024 Healthy Future Report. <br />   <br />  Click <a class="link" href="https://www.tevapharm.com/globalassets/tevapharm-vision-files/teva-esg-progress-report-disclosures-2024.pdf">here</a>  to read the complete 2024 Healthy Future Report Disclosures.</div>  
     </div>
     <br style="clear:both;"/>
    ]]>
   </content>
   <link rel="alternate" href="https://www.dailycsr.com/Teva-s-Global-Innovation-Strategy-Advancing-Healthcare-Through-Collaboration-and-Research_a4873.html" />
  </entry>
</feed>
